<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Epithelial Cells &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/epithelial-cells/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 14 Jan 2024 17:22:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Epithelial Cells &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>CA 15-3 and CEA Tumor Markers Used in the Diagnosis and Monitoring of Cancer</title>
		<link>https://bioengineer.org/ca-15-3-and-cea-tumor-markers-used-in-the-diagnosis-and-monitoring-of-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 14 Jan 2024 16:53:33 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Bone Metastases]]></category>
		<category><![CDATA[CA 15-3]]></category>
		<category><![CDATA[Cancer Diagnosis]]></category>
		<category><![CDATA[Cancer Management]]></category>
		<category><![CDATA[cancer research]]></category>
		<category><![CDATA[Carcinoembryonic Antigen]]></category>
		<category><![CDATA[CEA Tumor Markers]]></category>
		<category><![CDATA[CEACAM Family]]></category>
		<category><![CDATA[Cell Adhesion]]></category>
		<category><![CDATA[Early Detection]]></category>
		<category><![CDATA[Epithelial Cells]]></category>
		<category><![CDATA[Exon 19 Mutations]]></category>
		<category><![CDATA[Glycosylation]]></category>
		<category><![CDATA[HER2-Enriched]]></category>
		<category><![CDATA[Immunoglobulin Domains]]></category>
		<category><![CDATA[Liver Metastases]]></category>
		<category><![CDATA[Luminal Subtypes]]></category>
		<category><![CDATA[Metastasis]]></category>
		<category><![CDATA[Metastasis Location]]></category>
		<category><![CDATA[MUC1 Glycoprotein]]></category>
		<category><![CDATA[Pleural Effusions]]></category>
		<category><![CDATA[Quality of Life]]></category>
		<category><![CDATA[Serum Markers]]></category>
		<category><![CDATA[Treatment Response]]></category>
		<category><![CDATA[Triple Negative]]></category>
		<category><![CDATA[Tumor Burden]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=219284</guid>

					<description><![CDATA[CA 15-3 is an epitope of the MUC1 glycoprotein. MUC1 is a transmembrane mucosa-associated glycoprotein and contains a large extracellular domain, a transmembrane region and a cytoplasmic tail. The extracellular portion of MUC1 consists of numerous tandemly repeating peptide sequences. These repeats lead to a long and protruding structure of the protein and form a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">219284</post-id>	</item>
	</channel>
</rss>
